Literature DB >> 32354601

Impact of adherence to surgical and non-surgical components of infective endocarditis guidelines and recommendations.

Paul R Ingram1, Thomas L Carrello2, Aimee Lee Jones2, Michael Jb McCann3, Nick S R Lan4, Christopher Judkins3, Robert Larbalestier5, Laurens A Manning6, John R Dyer7.   

Abstract

BACKGROUND: Infective endocarditis (IE) is associated with significant morbidity and mortality. Non-adherence to IE guidelines and recommendations is frequent, and may adversely impact patient outcomes. AIM: To assess the impact of non-adherence to components of existing IE guidelines and recommendations on a composite outcome consisting of any of the following: mortality, unplanned cardiac surgery, embolic event or relapse of positive blood culture within six months of diagnosis.
METHODS: A single centre, retrospective cohort study.
RESULTS: Amongst 157 patients, there was inconsistent adherence to: initial diagnosis of an infective condition (87%), timely administration of antimicrobial therapy (82%), appropriateness of predominant antimicrobial regime (94%), appropriate management of the portal of entry (86%), multidisciplinary input (75%), end of antimicrobial therapy repeat echocardiography (60%) and adherence to indications for surgery (76%). Inpatient mortality was 12.1% (n = 19) and the composite adverse outcome occurred in 36 (22.9%) patients. In multivariate logistic regression analysis, infection of prosthetic device (adjusted odds ratio [95% confidence interval]; 2.43 [1.07-5.50]) and non-adherence to surgical guidelines (aOR 3.67 [1.60-8.47]) were significantly associated with an adverse outcome.
CONCLUSIONS: Our data suggests that adherence to differing components of IE management guidelines and recommendations varies and that non-adherence to surgical aspects of guidelines has the biggest impact in determining outcomes.
Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adherence; Guideline; Impact; Infective endocarditis; Recommendation

Mesh:

Year:  2020        PMID: 32354601     DOI: 10.1016/j.jiac.2020.04.005

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  1 in total

1.  A clinical and in vitro assessment of outpatient parenteral benzylpenicillin and ceftriaxone combination therapy for enterococcal endovascular infections.

Authors:  Paul R Ingram; Jacinta Ng; Claire Mathieson; Shakeel Mowlaboccus; Geoffrey Coombs; Edward Raby; John Dyer
Journal:  JAC Antimicrob Resist       Date:  2021-08-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.